ABCB1 and Alzheimer disease: In models of Alzheimer’s disease, concerns have been raised that the long-term inhibition of ABCB1 and ABCC1 may exacerbate neurodegeneration as a consequence of reduced β-amyloid clearance (Cirrito et al., 2005; Krohn et al., 2011).